After winning a breakthrough therapy designation for its Hunter syndrome enzyme replacement therapy, Denali Therapeutics is ...

Cells navigating in complex microenvironments frequently encounter narrow spaces that physically challenge migration.

Nader Yaghoubi, M.D., Ph.D., PathMaker’s Co-Founder and CEO, stated, “We are pleased to announce IRB approval for the CALM study, which allows us to commence enrollments shortly. Given the mechanisms ...

The human brain is a complex powerhouse, responsible for orchestrating thoughts, emotions, and memories. Its nerve cells ...

Applications are based on data from the DEVOTE study, which demonstrate the potential for the investigational higher dose regimen of nusinersen to advance the treatment of SMA CAMBRIDGE, Mass., Jan. 2 ...

This study uses all-optical electrophysiology methods to provide a valuable insight into the organization of cortical networks and their ability to balance the activity of groups of neurons with ...

While you'd be forgiven for confusing the upcoming "A Quiet Place Part III" with the franchise's third entry, the prequel "A Quiet Place: Day One," a proper follow-up continuing the Abbott family ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

The proposed rule, which draws inspiration from the Transparency, Readability, Understandability, Truth, and Helpfulness (TRUTH) in Labeling Act, aims to simplify food labels, making essential ...

a hit to his reputation and a decrease in his brand's value before his contract renegotiation with the record label this year. The suit added that UMG "understood the recording's inflammatory and ...